‘The Australasian Kidney Trials Network (AKTN) has been a member of the Queensland Clinical Trials Network (QCTN) since 2007. Being a member of this Network is instrumental to the success of our organisation as they provide a point of contact for both domestic and international organisations that seek to undertake clinical trials in Australia. Since becoming a member of QCTN, we have been exhibited at both domestic and international conference and trade meetings and this increase in exposure has ensured our Network has become a great success. In the past two years, the AKTN has gone from strength to strength and our membership with QCTN has resulted in increased interest and participation in our clinical trials due to the ease and availability of advertisements and organisational promotion,’ Melissa Bruce – Business Development Manager, Australasian Kidney Trials Network.

‘The Australasian Kidney Trials Network (AKTN) has been a member of the Queensland Clinical Trials Network (QCTN) since 2007. Being a member of this Network is instrumental to the success of our organisation as they provide a point of contact for both domestic and international organisations that seek to undertake clinical trials in Australia. Since becoming a member of QCTN, we have been exhibited at both domestic and international conference and trade meetings and this increase in exposure has ensured our Network has become a great success. In the past two years, the AKTN has gone from strength to strength and our membership with QCTN has resulted in increased interest and participation in our clinical trials due to the ease and availability of advertisements and organisational promotion,’ Melissa Bruce – Business Development Manager, Australasian Kidney Trials Network.

'The Queensland Life Sciences Globally Engaging Event was a great night and we were very happy as sponsors,' James Cameron - Senior Associate, McCullough Robertson.

'The Queensland Life Sciences Globally Engaging Event was a great night and we were very happy as sponsors,' James Cameron - Senior Associate, McCullough Robertson.

'Richard Bowen has spoken very positively of the role you play in the Queensland Biotech landscape and I look forward to explore with you and your colleagues areas of complementarity and alliance building,' High-profile, high-ranking South African Scientist.

'Richard Bowen has spoken very positively of the role you play in the Queensland Biotech landscape and I look forward to explore with you and your colleagues areas of complementarity and alliance building,' High-profile, high-ranking South African Scientist.

'QCTN's efforts in providing an effective springboard for CNS to access potential US clients have proved very successful and cost effective,' Mr Russell Neal - Director of Operations, Clinical Network Services (CNS).

'QCTN's efforts in providing an effective springboard for CNS to access potential US clients have proved very successful and cost effective,' Mr Russell Neal - Director of Operations, Clinical Network Services (CNS).

'Highly recommend to members looking for value for money and exposure for their brand,' Dr. Jeffery Smith - President & CEO, BioAssayLINK.

'Highly recommend to members looking for value for money and exposure for their brand,' Dr. Jeffery Smith - President & CEO, BioAssayLINK.

‘You need this course before starting the work,’ Grahame - QCTN's Clinical Trials Design & Management (for Study Coordinators) Course Attendee.

‘You need this course before starting the work,’ Grahame - QCTN's Clinical Trials Design & Management (for Study Coordinators) Course Attendee.

'A very practical, easy-to-follow guide to research,' Sally - QCTN's Clinical Trials Design (for Researchers) Course Attendee.

'A very practical, easy-to-follow guide to research,' Sally - QCTN's Clinical Trials Design (for Researchers) Course Attendee.

'Well organised event and an engaging speaker that provided some thought-provoking statistics on where our industry might be headed. Great networking opportunities afterwards,' James Cameron - Senior Associate, McCullough Robertson Lawyers - Dr. Steve Arlington Presentation Luncheon Attendee.

'Well organised event and an engaging speaker that provided some thought-provoking statistics on where our industry might be headed. Great networking opportunities afterwards,' James Cameron - Senior Associate, McCullough Robertson Lawyers - Dr. Steve Arlington Presentation Luncheon Attendee.

'It is much appreciated and great to see how well you guys promote your members,' James Cameron - Senior Associate, McCullough Robertson - Lawyers.

'It is much appreciated and great to see how well you guys promote your members,' James Cameron - Senior Associate, McCullough Robertson - Lawyers.

'On behalf of Queensland Government Japan Offices, I thank you for giving me and my team an opportunity to work with you. It was lots of fun and I believe we have successfully achieved our mission of further raising the profile of Queensland clinical trial capabilities in Japan. We look forward to working with you to follow up on the leads from last week,' Tak Adachi - Commissioner QGTIO Japan.

'On behalf of Queensland Government Japan Offices, I thank you for giving me and my team an opportunity to work with you. It was lots of fun and I believe we have successfully achieved our mission of further raising the profile of Queensland clinical trial capabilities in Japan. We look forward to working with you to follow up on the leads from last week,' Tak Adachi - Commissioner QGTIO Japan.

'I would like to commend you on your daily newsletter which provides me with relevant and up to date information on developments in clinical trials, drug development and other areas of biotechnology. This has benefited me greatly, not only increasing my knowledge in these areas, but also in understanding the issues which face my clients in this area and allow me to negotiate appropriate insurance coverage for their businesses,' Paul Kelly - R J Neville & Associates.

'I would like to commend you on your daily newsletter which provides me with relevant and up to date information on developments in clinical trials, drug development and other areas of biotechnology. This has benefited me greatly, not only increasing my knowledge in these areas, but also in understanding the issues which face my clients in this area and allow me to negotiate appropriate insurance coverage for their businesses,' Paul Kelly - R J Neville & Associates.

I would like to thank QCTN for the opportunity to attend the DIA in Atlanta this year. The industry knowledge gained from attending the DIA coupled with the extensive networking opportunities resulted in trial opportunities within one week of returning from the conference. We will definitely be attending the conference annually, as this has been the most successful business development tool we have utilised,' Aletha Ward - General Manager, Sunnybank Research Centre.

I would like to thank QCTN for the opportunity to attend the DIA in Atlanta this year. The industry knowledge gained from attending the DIA coupled with the extensive networking opportunities resulted in trial opportunities within one week of returning from the conference. We will definitely be attending the conference annually, as this has been the most successful business development tool we have utilised,' Aletha Ward - General Manager, Sunnybank Research Centre.

QCTN has provided invaluable support and assistance to WRI in regard to the promotion of our services to the local, national and international clinical trials community. Our services are now being actively promoted worldwide which is something we could never have done on our own. I also firmly believe that 'all together' we, the members, have a far more significant and credible offering to the industry than if we were still trying to go-it-alone,' Vincent McFarlane - General Manager, The Wesley Research Institute.

QCTN has provided invaluable support and assistance to WRI in regard to the promotion of our services to the local, national and international clinical trials community. Our services are now being actively promoted worldwide which is something we could never have done on our own. I also firmly believe that 'all together' we, the members, have a far more significant and credible offering to the industry than if we were still trying to go-it-alone,' Vincent McFarlane - General Manager, The Wesley Research Institute.